Oral lopinavir use and human papillomavirus infection in HIV-positive women

Cecile D. Lahiri, Katherine B. Dugan, Xianhong Xie, Laura Reimers, Robert D. Burk, Kathryn Anastos, Leslie Stewart Massad, Isam Eldin Eltoum, Xiaonan Xue, Gypsyamber D'Souza, Lisa Flowers, Joel M. Palefsky, Lisa Rahangdale, Howard D. Strickler, Ighovwerha Ofotokun

Research output: Contribution to journalLetter

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)e63-e66
JournalJournal of Acquired Immune Deficiency Syndromes
Volume70
Issue number2
DOIs
StatePublished - Oct 1 2015

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Lahiri, C. D., Dugan, K. B., Xie, X., Reimers, L., Burk, R. D., Anastos, K., Massad, L. S., Eltoum, I. E., Xue, X., D'Souza, G., Flowers, L., Palefsky, J. M., Rahangdale, L., Strickler, H. D., & Ofotokun, I. (2015). Oral lopinavir use and human papillomavirus infection in HIV-positive women. Journal of Acquired Immune Deficiency Syndromes, 70(2), e63-e66. https://doi.org/10.1097/QAI.0000000000000752